SciELO - Scientific Electronic Library Online

vol.96 número3Carcinoma de células de merkel: Presentación de un caso con localización y tamaño atípicosTrasplante de cabello en el liquen plano pilar índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados




  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO


Revista argentina de dermatología

versión On-line ISSN 1851-300X


JAQUE, A; ORTIZ, E; VIAL, V  y  VERA-KELLET, C. Severe atopic dermatitis with generalized molluscum contagiosum and their response to intravenous immunoglobulin: Case report and literature review. Rev. argent. dermatol. [online]. 2015, vol.96, n.3, pp.14-21. ISSN 1851-300X.

Background: atopic dermatitis (AD) is a chronic inflammatory skin disease that affects between 1 to 3% of adults. Case: we report a case of a 23-years old woman with history of asthma, allergic rhinitis and severe atopic dermatitis (SAD), with poor previous response to four systemic treatments. She consulted due to exacerbation of her AD and a four month-course of progressive papular lesions, compatible with molluscum contagiosum. Laboratory evaluation showed hypereosinophilia and IgE levels > 20.000. Because of the severity of the clinical condition and taking in consideration the patient´s immunosupression state, intravenous immunoglobulin (IVIg) 0,4 mg/kg/day was started for five days and three cycles, with good response of her cutaneous lesions. Discussion: the standard therapies for AD are mainly focused on symptomatic relief and its clinical efficacy is often insufficient. The treatment with IVIg is effective in some dermatological autoinflammatory diseases and there are few reports in this matter, especially in children. Other treatments available for these cases are interferon-gamma and omalizumab, but the actual evidence is insufficient and it is required more prospective studies to support their use.

Palabras clave : Severe atopic dermatitis; Treatment; Intravenous immunoglobulin; Omalizumab; Interferon-gamma.

        · resumen en Español     · texto en Español


Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons